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A decline in cellular homeostasis in older individuals 
underlies age-related pathologies like osteoporosis and 
osteoarthritis.  In this issue of Impact Aging, Jiang et al. 
[1] report key differences in the patterns of expressed 
mRNAs  in  bone-marrow  mesenchymal  stem  cells 
(bmMSCs) of young donors compared with old human 
donors.    The  distinct  subsets  of  expressed  genes 
associated  with  glycobiology  are  consistent  with  the 
underlying age-related decline in bone marrow function. 
 
It is now well established that in older individuals stem 
cells can become “aged” and thus incapable of renewing 
surrounding tissues and organs as efficiently as young 
individuals.    Experimental  and  clinical  evidence  has 
revealed  the  importance  of  stem  cell  aging  in  bone 
marrow transplants, as recipients of bone marrow from 
older donors do not fare as well as recipients of bone 
marrow  from  younger  donors  [2,3].    However,  the 
molecular  mechanisms  governing  stem  cell  aging  are 
not well understood.  An important first step towards 
this goal is to delineate the gene expression differences 
between  stem  cells  from  young  and  old  individuals.  
Bone marrow stem cells are particularly well suited for 
such  studies,  as  they  are  relatively  easy  to  purify  to 
homogeneity.    Jiang  et  al  (2011)  investigated  mRNA 
expression  profiles  of  bmMSCs  from  normal 
individuals and osteoarthritis patients and analyzed the 
data to address age- and osteoarthritis-related changes 
in  mRNAs  expressed  in  these  cells.    Apart  from  the 
expected differences in the expression of proliferation 
and  cell  cycle-related  genes,  bmMSCs  showed  age-
increases in the expression of genes associated with the 
degradation of N-glycans and glycosaminoglycans and 
with  the  biosynthesis  of  glycosphingolipids.  These 
results reveal major differences in the glycobiology and 
glycan  compostion  of  young  and  old  bmMSCs, 
associated  with  age-related  changes  in  the  cellular 
responses  to  autocrine  and  paracrine  signals.    The 
difference  in  glycan  pathways  may  not  be  limited  to 
bmMSCs  or  even  to  stem  cells,  but  could  be  more 
widely prevalent among other cell types.  For example 
changes  in  brain  glycoprotein  composition  were 
reported in aging brain [4]. 
 
Gene expression analyses similar to that undertaken by 
Jiang and coworkers can provide critical insight into the 
molecular mechanisms of aging.   The authors examine 
the implication of their findings by testing the ability of 
bmMSCs  to  respond  to  Na2SO4,  a  treatment  that 
increases  the  sulfation  of  proteoglycans.      BmMSCs 
responded  to  Na2SO4  treatment  by  inducing  DNA 
synthesis,  but  the  response  was  stronger  in  bmMSCs 
from  aged  donors,  correlating  with  higher  SULF1 
mRNA expression levels.   Further studies are required 
to  address  how  Na2SO4  treatment  affects  DNA 
synthesis,  whether  SULF1  is  implicated  in  this 
differential response, and why the response is different 
in adult and aged bmMSCs.  The report also sets the 
stage  for  more  studies  of  the  molecular  mechanism 
whereby  changes  in  the  expression  of  other  glycan 
pathway genes affect aging.  For example HEXA and 
HEXB  mRNAs,  encoding  two  hexoseaminidases 
important  for  the  degradation  of  glycosphingolipids, 
were  upregulated  in  aged  bmMSCs.    Further 
investigation   will   reveal    whether  this  differential  
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and thus affects cellular signaling.  In this regard, it was 
proposed earlier that hexoseaminidase inhibitors could 
be exploited for the treatment of osteoarthritis [5]. 
 
In  sum,  studying  differences  in  gene  expression  in 
persons of different ages can reveal specific molecular 
signatures  of  physiologic  and  pathologic  states.  
Accordingly,  the  patterns  of  expressed  genes  are 
increasingly  recognized  as  providing  valuable 
frameworks for the diagnosis and management of age-
related diseases. 
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